It exists primarily as GLP-1 (7-36) amide and GLP-1 (7-37)
Retatrutide is being studied in people with obesity, overweight and type 2 diabetes, but it is not currently approved as a diabetes or weight loss treatment in the UK
At concentrations where neither peptide alone is fully effective, the combination kills significantly more bacteria than either individual peptide
Compounded GLP-1 Options: Quality, Sourcing, and Regulatory Oversight Compounded GLP-1 medications (compounded semaglutide and tirzepatide) are prepared by licensed 503A compounding pharmacies under state pharmacy board oversight and FDA guidance
Key Takeaways Sermorelin is a prescription peptide that is often used as a non-DEA regulated alternative to testosterone for improving muscle mass and overall energy, by stimulating the bodys production of human growth hormone (HGH)
Because of its triple-action mechanism, it appears to have a broader metabolic impact compared with traditional GLP-1 agonists like Wegovy and Mounjaro